Visualization Technology is now part of GE Medical Systems. The deal to acquire the developer of image-guided surgery (IGS) products, announced earlier this year (SCAN 2/20/02), is the second such acquisition by GE. The first, involving Surgical Insights
Visualization Technology is now part of GE Medical Systems. The deal to acquire the developer of image-guided surgery (IGS) products, announced earlier this year (SCAN 2/20/02), is the second such acquisition by GE. The first, involving Surgical Insights of Evanston, IL, closed in February. Visualization Technology is a pioneer in electromagnetic-based IGS. Its innovative technology allows continuous navigation during surgical procedures regardless of the patient's position or the location of surgical instruments.
The new business, called GE Medical Systems Navigation and Visualization, will develop and market IGS products incorporating an open platform that works in conjunction with all manufacturers' intraoperative tools, instruments, devices, and implants. This new business combines the VTI and Surgical Insights product offerings, along with future IGS offerings as they are added to the GE Medical Systems product line. The first product offering from this new business will be the OEC FluoroTrak 9800 Plus, an integrated surgery imaging solution, which will be available this summer.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.